当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2012年第35期 > 正文
编号:12352862
VEGF干扰慢病毒载体的构建及其在MHCC97L细胞中的表达(3)
http://www.100md.com 2012年12月15日 丁治国等
第1页

    参见附件。

     [4] Hammond SM,Bernstein E,Beach D,et al. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells [J]. Nature,2000,404(6775):293-296.

    [5] Brummelkamp TR,Bernards R,Agami R. A system for stable expression of short interfering RNAs in mammalian cells[J]. Science,2002,296(5567):550-553.

    [6] Pushparaj PN,Aarthi JJ,Manikandan J,et al. siRNA,miRNA,and shRNA:in vivo applications [J]. J Dent Res,2008,87(11):992-1003.

    [7] Heilbronn R,Weger S. Viral vectors for gene transfer:current status of gene therapeutics [J]. Handb Exp Pharmacol,2010,(197):143-170.

    [8] Leite LH,Sharma NM,Bafna S,et al. Construction and validation of lentiviral vector carrying rat neuronal nitric oxide synthase in vitro and in vivo [J]. J Neurosci Methods,2012,211(1):77-83.

    [9] Liu X,Tang Z,Zhang Y,et al. Lentivirally overexpressed T-bet regulates T-helper cell lineage commitment in chronic hepatitis B patients [J]. Mol Med Report,2012,6(2):361-366.

    [10] Chang SH,Chung YS,Hwang SK. Lentiviral vector-mediated shRNA against AIMP2-DX2 suppresses lung cancer cell growth through blocking glucose uptake [J]. Mol Cells,2012,33(6):553-562.

    (收稿日期:2012-10-10 本文编辑:谷俊英)

    

您现在查看是摘要介绍页,详见PDF附件(2999kb)